(Q33474188)

27 July 2017

Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinoma (English)

1 reference

27 July 2017

multiple drug resistance

1 reference

1 reference

Lorraine O'Driscoll

10

0 references

author name string

Naomi Walsh

1

1 reference

27 July 2017

Annemarie Larkin

2

1 reference

27 July 2017

Susan Kennedy

3

1 reference

27 July 2017

Lisa Connolly

4

1 reference

27 July 2017

Jo Ballot

5

1 reference

27 July 2017

Wei Ooi

6

1 reference

27 July 2017

Giuseppe Gullo

7

1 reference

27 July 2017

John Crown

8

1 reference

27 July 2017

Martin Clynes

9

1 reference

27 July 2017

24 June 2009

1 reference

27 July 2017

1 reference

27 July 2017

9

1 reference

27 July 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2490-9-6

27 July 2017

0 references

cites work

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

Treatment of metastatic renal cell carcinoma

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

MDR1/P-glycoprotein and MRP-1 drug efflux pumps in pancreatic carcinoma

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

Risk factors for renal cell cancer: the multiethnic cohort

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

MDR1/P-glycoprotein and MRP-1 mRNA and protein expression in non-small cell lung cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

The pharmacology of cancer resistance.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

14 July 2018

Cancer statistics, 2007

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

Intrinsic chemotherapy resistance to the tubulin-binding antimitotic agents in renal cell carcinoma.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

Introduction of clusterin gene into human renal cell carcinoma cells enhances their resistance to cytotoxic chemotherapy through inhibition of apoptosis both in vitro and in vivo

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

Expression of the multiple drug resistance gene in human renal cell carcinoma depends on tumor histology, grade, and stage.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

P-glycoprotein functions and substrates: possible roles of MDR1 gene in the kidney

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

A new mdr-1 encoded P-170 specific monoclonal antibody: (6/1C) on paraffin wax embedded tissue without pretreatment of sections.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

MDR1 RNA levels in human renal cell carcinomas: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

Detection of drug resistance and P-glycoprotein in human renal cell carcinomas.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

Multiple drug resistance gene expression in human renal cell cancer is associated with the histologic subtype

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

Investigation of MRP-1 protein and MDR-1 P-glycoprotein expression in invasive breast cancer: a prognostic study.

14 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-9-6

Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-9-6

A new monoclonal antibody, P2A8(6), that specifically recognizes a novel epitope on the multidrug resistance-associated protein 1 (MRP1), but not on MRP2 nor MRP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-9-6

Increased expression of lung resistance-related protein in lower grade urothelial carcinoma of the renal pelvis and ureter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-9-6

Prognostic variables to predict cancer-related death in incidental renal tumours

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

Expression of genes involved in chemoresistance, proliferation and apoptosis in clinical samples of renal cell carcinoma and correlation with clinical outcome

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

Expression of P-glycoprotein and multidrug resistance in renal cell carcinoma.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723136

Renal cell carcinoma: molecular and genetic markers as new prognostic and therapeutic tools

31 October 2018

1 reference

12 December 2020

Expression patterns of multidrug-resistance (MDR1), multidrug resistance-associated protein (MRP),glutathione-S-transferase-pi (GST-pi) and DNA topoisomerase II (Topo II) genes in renal cell carcinomas and normal kidney

1 reference

12 December 2020

Gemcitabine: a phase II study in patients with advanced renal cancer

1 reference

12 December 2020

Obesity, hypertension, and the risk of kidney cancer in men

1 reference

12 December 2020

Immunocytochemical detection of P-glycoprotein: initial expression correlates with survival in renal cell carcinoma patients

1 reference

12 December 2020

Surgery in advanced and metastatic renal cell carcinoma

1 reference

12 December 2020

Is the expression of multidrug resistance gene product a prognostic indicator for the clinical outcome of patients with renal cancer?

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2490-9-6

1 reference

Dimensions Publication ID

27 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2490-9-6

9 September 2019

1 reference

27 July 2017

1 reference